HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Scott Lonning Selected Research

Antibodies

12/2011Antibody targeting of TGF-β in cancer patients.
4/2010Blockade of TGF-beta enhances tumor vaccine efficacy mediated by CD8(+) T cells.
5/2008Transforming growth factor beta subverts the immune system into directly promoting tumor growth through interleukin-17.
6/2006Bone sialoprotein mediates the tumor cell-targeted prometastatic activity of transforming growth factor beta in a mouse model of breast cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Scott Lonning Research Topics

Disease

16Neoplasms (Cancer)
09/2014 - 06/2006
6Neoplasm Metastasis (Metastasis)
12/2012 - 06/2006
4Breast Neoplasms (Breast Cancer)
01/2011 - 06/2006
2Leukemia
09/2014 - 08/2014
2Fibrosis (Cirrhosis)
01/2013 - 09/2008
2Glioma (Gliomas)
01/2011 - 11/2009
2Carcinogenesis
05/2008 - 06/2006
1Cholangiocarcinoma
01/2013
1Liver Diseases (Liver Disease)
01/2013
1Hepatic Insufficiency
01/2013
1Pancreatic Neoplasms (Pancreatic Cancer)
09/2012
1Obesity
07/2011
1Prostatic Neoplasms (Prostate Cancer)
01/2011
1Glioblastoma (Glioblastoma Multiforme)
01/2011
1Carcinoma (Carcinomatosis)
04/2010
1Heart Failure
09/2008
1Myocardial Infarction
09/2008
1Ventricular Remodeling
09/2008
1Renal Cell Carcinoma (Grawitz Tumor)
07/2008
1Infections
07/2008
1Colonic Neoplasms (Colon Cancer)
05/2008
1Airway Remodeling
03/2008
1Asthma (Bronchial Asthma)
03/2008
1Inflammation (Inflammations)
03/2008

Drug/Important Bio-Agent (IBA)

11Transforming Growth Factor beta (TGF-beta)IBA
05/2010 - 06/2006
5Transforming Growth Factors (Transforming Growth Factor)IBA
01/2013 - 06/2006
4CytokinesIBA
12/2012 - 05/2008
4AntibodiesIBA
12/2011 - 06/2006
3Phosphotransferases (Kinase)IBA
09/2014 - 05/2010
3Monoclonal AntibodiesIBA
01/2013 - 11/2009
3VaccinesIBA
04/2010 - 11/2009
2Tyrosine (L-Tyrosine)FDA Link
09/2014 - 08/2014
2Epidermal Growth Factor (EGF)IBA
09/2014 - 02/2014
2Glucose (Dextrose)FDA LinkGeneric
08/2014 - 07/2011
2Protein Subunit VaccinesIBA
11/2009 - 11/2009
1Pyruvate Dehydrogenase Acetyl-Transferring KinaseIBA
08/2014
1Pyruvic Acid (Pyruvate)IBA
08/2014
1Serine (L-Serine)FDA Link
08/2014
1Pyruvate Dehydrogenase (Lipoamide)-Phosphatase (Pyruvate Dehydrogenase Phosphatase)IBA
08/2014
1Pyruvate Dehydrogenase Complex (Dehydrogenase Complex, Pyruvate)IBA
08/2014
1Phosphoric Monoester Hydrolases (Phosphatases)IBA
08/2014
1Oxidoreductases (Dehydrogenase)IBA
08/2014
1Sirtuin 3IBA
02/2014
1Lysine (L-Lysine)FDA Link
02/2014
1AcetyltransferasesIBA
02/2014
1CollagenIBA
01/2013
1Thioacetamide (Thioacetamid)IBA
01/2013
1Small Interfering RNA (siRNA)IBA
01/2013
1ArginaseIBA
12/2012
1CarcinogensIBA
12/2012
1IntegrinsIBA
09/2012
1MethyltransferasesIBA
01/2011
1DNA (Deoxyribonucleic Acid)IBA
01/2011
1Therapeutic UsesIBA
05/2010
1LY2109761IBA
05/2010
1Neutralizing AntibodiesIBA
05/2010
1Cancer VaccinesIBA
04/2010
1EpitopesIBA
11/2009
1AntigensIBA
11/2009
1Interleukin-15 (Interleukin 15)IBA
11/2009
1Transforming Growth Factor beta1 (TGF beta 1)IBA
07/2008
1Interleukin-17 ReceptorsIBA
05/2008
1Interleukin-17 (Interleukin 17)IBA
05/2008
1Death Domain ReceptorsIBA
05/2008
1InterleukinsIBA
05/2008
1LigandsIBA
05/2008
1Interleukin-6 (Interleukin 6)IBA
05/2008
1Conditioned Culture MediaIBA
03/2007
1Transcription Factors (Transcription Factor)IBA
03/2007
1Interleukin-2 (IL2)IBA
03/2007
1Interleukin-10 (Interleukin 10)IBA
03/2007
1Proteins (Proteins, Gene)FDA Link
06/2006
1Integrin-Binding SialoproteinIBA
06/2006

Therapy/Procedure

2Therapeutics
12/2012 - 01/2011
1Drug Therapy (Chemotherapy)
09/2012
1Ligation
09/2008
1Subcutaneous Injections
07/2008
1Intravenous Injections
07/2008
1Intranasal Administration
03/2008